Physician

Durga Venkatalaksh Madala, M.D.

According to 2025 Medicare claims, Durga Madala, M.D. (NPI: 1184650772) practices cardiology in the San Jose-Sunnyvale-Santa Clara, CA market, with the plurality of this provider's patient population coming from Santa Clara, CA. This provider's primary affiliated billing organization is DURGA MADALA, M.D., INC. (NPI: 1033146287; TIN: 202044239) and primary practice location at 95030-3306.

Madala's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,894 traditional Medicare patients, billed 10,659 HCPCS/CPT codes, and received $1,078,277 in Medicare payments. The top billing code was 93351 (Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report). Part D data shows 15,579 prescription claims across 1,811 beneficiaries totaling $3,267,134 in drug costs, led by Eliquis (Apixaban). DME data shows 30 claims. Open Payments data shows 106 records totaling $2,355. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $427,774 to $1,078,277. Similarly, Part D prescription costs have moved sharply higher in recent years, from $637,594 to $3,267,134. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $46,153 to $2,678.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	865	6,816	$427,774
2016	941	6,337	$350,408
2017	1,108	7,807	$475,966
2018	1,284	8,212	$493,809
2019	1,417	8,618	$570,061
2020	1,359	8,125	$618,615
2021	1,573	9,319	$749,402
2022	1,655	9,541	$762,890
2023	1,714	9,053	$778,202
2024	1,894	10,659	$1,078,277

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	593	6,446	$637,594
2016	655	6,920	$735,340
2017	769	8,165	$882,697
2018	943	8,810	$1,141,622
2019	1,074	9,308	$1,372,358
2020	1,205	10,446	$1,743,602
2021	1,338	11,150	$2,010,151
2022	1,455	12,121	$2,284,090
2023	1,620	13,771	$2,908,736
2024	1,811	15,579	$3,267,134

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	17	262	$44,452
2016	22	339	$29,898
2017	37	251	$9,687
2018	34	355	$13,600
2019	19	380	$12,032
2020	14	204	$6,815
2021	N/R	155	$5,187
2022	N/R	66	$2,542
2023	N/R	48	$1,791
2024	N/R	30	$1,173

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93351	Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report	258	261	$227
93880	Ultrasound of both sides of head and neck blood flow	649	654	$197
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	1,248	1,371	$191
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,520	3,220	$114
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	1,170	1,766	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	803	48,884	$935,769
Repatha Sureclick	Evolocumab	669	35,902	$691,589
Jardiance	Empagliflozin	358	18,931	$361,161
Xarelto	Rivaroxaban	258	17,715	$322,207
Farxiga	Dapagliflozin Propanediol	106	5,519	$102,981

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	15	$947
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	15	$226

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	106	$2,355	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Durga Venkatalaksh Madala, M.D.?

Tedicare shows public-source Medicare data for Durga Venkatalaksh Madala, M.D. (NPI 1184650772), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Durga Venkatalaksh Madala, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Durga Venkatalaksh Madala, M.D.?

Durga Venkatalaksh Madala, M.D. is linked to DURGA MADALA, M.D., INC. (billing NPI 1033146287) in the available physician profile data.

Does Durga Venkatalaksh Madala, M.D. have Open Payments data?

Durga Venkatalaksh Madala, M.D. has 106 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.